Segment Reporting (Tables)

6 Months Ended

Jun. 30, 2024

Segment Reporting [Abstract]

Schedule of Segment Reporting Information, by Segment

Segment data were as follows:

	For the Six Months Ended June 30,				For the Three Months Ended June 30,
(in millions)	2024		2023		2024		2023
Net revenues:
Smokeable products	$	10,401	$	10,910	$	5,495	$	5,820
Oral tobacco products	1,362		1,308		711		680
All other	22		9		3		8
Net revenues	$	11,785	$	12,227	$	6,209	$	6,508
Earnings before income taxes:
OCI:
Smokeable products	$	5,246	$	5,349	$	2,807	$	2,846
Oral tobacco products	532		859		97		443
All other	(172)		(13)		(111)		(4)
Amortization of intangibles	(64)		(45)		(37)		(27)
General corporate expenses	(335)		(488)		(223)		(353)
Operating income	5,207		5,662		2,533		2,905
Interest and other debt expense, net	515		486		261		257
Net periodic benefit income, excluding service cost	(49)		(62)		(25)		(31)
(Income) losses from investments in equity securities	(414)		(47)		(119)		(127)
Gain on the sale of IQOS System commercialization rights	(2,700)		—		(2,700)		—
Earnings before income taxes	$	7,855	$	5,285	$	5,116	$	2,806

Schedule of Tobacco and Health and Certain Other Litigation Items

We recorded pre-tax charges related to tobacco and health and certain other litigation items as follows:

	For the Six Months Ended June 30,				For the Three Months Ended June 30,
(in millions)	2024		2023		2024		2023
Smokeable products segment	$	38	$	52	$	20	$	40
General corporate expenses	30		338		24		240
Interest and other debt expense, net	—		11		—		10
Total	$	68	$	401	$	44	$	290